These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15777209)

  • 1. CXCR3-binding chemokines: novel multifunctional therapeutic targets.
    Lazzeri E; Romagnani P
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):109-18. PubMed ID: 15777209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
    Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
    Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
    J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
    Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
    J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
    Soejima K; Rollins BJ
    J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.
    Romagnani P; Annunziato F; Lasagni L; Lazzeri E; Beltrame C; Francalanci M; Uguccioni M; Galli G; Cosmi L; Maurenzig L; Baggiolini M; Maggi E; Romagnani S; Serio M
    J Clin Invest; 2001 Jan; 107(1):53-63. PubMed ID: 11134180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Zisman DA; Xue YY; Li K; Ardehali A; Ross DJ; Strieter RM
    J Immunol; 2003 Nov; 171(9):4844-52. PubMed ID: 14568964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
    Xanthou G; Williams TJ; Pease JE
    Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR3 ligands in disease and therapy.
    Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
    Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome.
    Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC; Reinhart TA
    J Med Primatol; 2003 Aug; 32(4-5):247-64. PubMed ID: 14498985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
    Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
    Colvin RA; Campanella GS; Manice LA; Luster AD
    Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
    Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
    Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
    Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
    Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets.
    Karin N; Wildbaum G; Thelen M
    J Leukoc Biol; 2016 Jun; 99(6):857-62. PubMed ID: 26657511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
    Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
    J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic neuritis: chemokine receptor CXCR3 and its ligands.
    Sørensen TL; Roed H; Sellebjerg F
    Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.
    Cox MA; Jenh CH; Gonsiorek W; Fine J; Narula SK; Zavodny PJ; Hipkin RW
    Mol Pharmacol; 2001 Apr; 59(4):707-15. PubMed ID: 11259614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.